Press Releases Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Real-time Estimate Cboe BZX Other stock markets 10:45:11 2024-06-10 am EDT			5-day change	1st Jan Change
21.04 ^USD	-0.45%		-6.36%	-42.87%

May. 28	Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License	MT
May. 28	Prothena Announces Bristol Myers Squibb Opt-In for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prothena : Corporate Overview	May. 29	PU
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	May. 28	BU
Prothena: Q1 Earnings Snapshot	May. 08	AQ
Prothena : Corporate Overview	May. 08	PU
Prothena Reports First Quarter 2024 Financial Results and Business Highlights	May. 08	BU
Prothena to Report First Quarter 2024 Financial Results on May 8	May. 01	BU
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	Apr. 16	AQ
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	Apr. 15	BU
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	Mar. 29	PU
Prothena to Participate in Upcoming Healthcare Conferences	Mar. 05	BU
Prothena Appoints David Ford to Newly Created Chief People Officer Position	Mar. 04	BU
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	Feb. 21	BU
Prothena: Q4 Earnings Snapshot	Feb. 15	AQ
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights	Feb. 15	BU
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	Feb. 08	BU
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs	Jan. 08	BU
Prothena: Q3 Earnings Snapshot	Nov. 02	AQ
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights	Nov. 02	BU
Prothena to Report Third Quarter 2023 Financial Results on November 2	23-10-26	BU
AL Amyloidosis Pipeline, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)	23-09-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Press Releases

Filters